Hemo Organic Ltd Reports Net Loss, Qualified Audit Opinion for FY26

Net Loss: ₹-0.7781 crore
Total Income: ₹0.929 crore

Reader Takeaway: Qualified audit opinion and net losses raise concerns; preferential issue provides some capital.

What just happened

Hemo Organic Limited reported a net loss of ₹0.7781 crore for the financial year ended March 31, 2026. The company's total income stood at ₹0.929 crore during the same period. Separately, the statutory auditors, MAAK & Associates, issued a qualified opinion on the financial statements.

Why this matters

The qualified audit opinion raises concerns about the reliability of the company's reported financial figures, particularly trade receivables, trade payables, and loans and advances. This, coupled with consistent net losses and negative operating cash flow, signals potential financial distress for Hemo Organic.

The backstory

The company has been navigating financial challenges, as evidenced by the negative cash flow from operations amounting to ₹-1.4581 crore for FY26. Accumulated losses have also exceeded the company's paid-up capital, creating uncertainty about its long-term viability.

What changes now

Hemo Organic has raised ₹1.0625 crore by allotting convertible warrants on a preferential basis, with 25% upfront payment received in February 2026. These warrants are exercisable within 18 months. This capital infusion may provide some short-term relief but doesn't address the core issues highlighted by the auditor.

Risks to watch

The primary risks include the qualified audit opinion, questioning the accuracy of financial balances. Persistent net losses and negative operating cash flow indicate an ongoing struggle to generate sustainable profits and manage core business operations effectively.

Peer comparison

Information on direct peers' recent financial performance and audit opinions is not available in the provided text.

Context metrics (time-bound)

For the year ended March 31, 2026:

• Total Income: ₹0.929 crore
• Net Loss: ₹-0.7781 crore
• Basic EPS: ₹-2.24
• Total Assets: ₹4.4611 crore
• Negative cash flow from operations: ₹-1.4581 crore

What to track next

Investors should closely monitor the company's efforts to address the auditor's qualifications, improve operating cash flow, and the potential exercise of the recently issued warrants. The company's ability to achieve profitability and strengthen its internal controls will be crucial.